NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Ned Sharpless photo
Norman E. “Ned” Sharpless, M.D., who is currently director of the National Cancer Institute, was named acting commissioner Tuesday to replace FDA Commissioner Scott Gottlieb, M.D. Gottlieb unexpectedly announced his resignation March 5.
NCBiotech entry
North Carolina’s Research Triangle region is among the nation’s largest and fastest-growing markets in the life sciences, according to a new report by Los Angeles-based CBRE Group, the world’s largest commercial real estate services and investment firm.
IQVIA logo
To add momentum to the fast-growing field of precision medicine, Durham-based IQVIA has launched a patented new technology platform for life science customers to access big data needed for a wide range of research activities.
Personalized Medicine Research and Adoption Forum
The Personalized Medicine Coalition promotes policies that support personalized medicine and encourages physicians to integrate personalized medicine in clinical settings.
Cellectis logo
Paris-based biotechnology company Cellectis announced plans today to invest nearly $70 million and create 200 jobs in Raleigh, at what will become its first North American manufacturing facility.
iStock photo of girl eating burger
Want to know what people think of Raleigh? Or Charlotte? Where to buy your next McMeal? Then check out Numbeo. It's saying Raleigh and Charlotte are among the best metros in the world for quality of life.
Sagent Pharmaceuticals North Raleigh factory
A north Raleigh drug-manufacturing site purchased in 2014 by Denmark-based Xellia Pharmaceuticals has been sold again -- this time to Sagent Pharmaceuticals of Schaumburg, Illinois.
Precision BioSciences loto
Durham-based Precision BioSciences, a genome-editing company focused on creating better foods and medicines, wants to raise up to $100 million in an initial public offering (IPO) of stock.
Dignify Therapeutics logo
Dignify Therapeutics, a virtual drug development company in Research Triangle Park, has received a $3.6 million federal grant to help develop its lead drug candidate for a future Phase 1 clinical study.
Investor panel at 2019 CED Life Science Conference
A panel of venture investment fund managers offered their insights into raising venture capital in the life sciences Wednesday during the 2019 CED Life Science Conference at the Raleigh Convention Center.
John Carreyrou photo
For any bioscience entrepreneurs in North Carolina who may be tempted to exaggerate claims about their products and technologies, investigative journalist John Carreyrou has some advice: do so at your own peril.
Several North Carolina Biotechnology Center portfolio companies are among the array of life science startups presenting their wares at the 2019 CED Life Science Conference today and Wednesday at the Raleigh Convention Center, including some that presented a year ago.
Shutterstock photo of street crowd
Population screening can use genetic information to identify seemingly healthy people who harbor a high risk of a hereditary disease, well before they become ill.
Climate change iStock image
It’s no secret that agriculture is highly dependent on climate, and the effects of global warming on crops are a complex problem. Those recognitions were jumping-off points for discussions from executives of two of North Carolina’s leading global agricultural biotechnology companies during NCBiotech's Ag Tech Professional Forum.

With uncertain weather forecast, the NCBiotech RTP office is opening at noon on Wednesday February 20.

Many of us will be checking in from home. Please stay safe out there.